ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,769, issued on Nov. 11, was assigned to Pacesetter Inc. (Sylmar, Canada).
"Method and device for managing pacing therapy based on interventricular septal activity" was invented by David Muller (Sylmar, Calif.) and Raffaele Corbisiero (Sylmar, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, devices and program products are provided for managing a pacing therapy using an implantable medical device (IMD). The methods, devices and program products sense cardiac activity (CA) signals at electrodes located proximate to multiple left ventricular (LV) sites and a right ventricular (RV) site of the heart and utilizing one or more processors to...